Giocon Pharma Limited, a active public limited company, was established on 06 February 1996 in Visakhapatnam, Andhra Pradesh, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232AP1996PLC023127. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.32 Cr.
Formerly known as Ion Pharmaceuticals Limited. It upholds a compliant status. Its leadership includes Ramprasadreddy Vennapusa (Additional Director), Dattatreya Sarma Aradyula (Director), Sankeerth Ram Tallapragada (Additional Director). Past directors included Dinesh Kumar Gadde, Seetaramaiah Mangalapalli, Akhtar Uzzaman. It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 29 September 2023, with the balance sheet filed on 31 March 2023. It is based at D.No.8-415/2, Pedagdil Near Sai Baba Temple, Visakhapatnam, Andhra Pradesh, 530040.
U24232AP1996PLC023127
023127
06 February 1996
₹1.50 Cr
₹1.32 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Giocon Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramprasadreddy Vennapusa | Additional Director | 24 Dec 2019 | Current |
| Dattatreya Sarma Aradyula | Director | 31 Jul 2020 | Current |
| Sankeerth Ram Tallapragada | Additional Director | 24 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Dec 2017 | Past |
| Pramod Abcsdd | Director | 29 Jan 2020 | Past |
| Pramod Abcsdd | Director | 31 Jul 2020 | Past |
| Pramod Abcsdd | Director | 20 May 2016 | Past |
| Pramod Abcsdd | Director | 18 Dec 2017 | Past |
| Pramod Abcsdd | Director | 16 Jul 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Giocon Pharma Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 96.31% decrease. The company also saw a substantial fall in profitability, with a 2105.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Giocon Pharma had a promoter holding of 38.43% and a public holding of 61.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Feb 2015 | City Union Bank Limited | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Giocon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Giocon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Giocon Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Giocon Pharma Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Giocon Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada. was completed.
Dattatreya Sarma Aradyula was appointed as a Director was appointed as a Director on 31 Jul 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Ramprasadreddy Vennapusa was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2019 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
Progress on Sankeerth Ram Tallapragada was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2019 & has been associated with this company since 5 years 11 months . was documented.
Progress on A charge with City Union Bank Limited amounted to Rs. 0.50 Cr with Charge ID 10552833 was registered on 13 Feb 2015. was documented.
The CIN of Giocon Pharma Limited is U24232AP1996PLC023127.
Giocon Pharma Limited is headquartered at D.No.8-415/2, Pedagdil Near Sai Baba Temple, Visakhapatnam, Andhra Pradesh, 530040.
Giocon Pharma Limited was incorporated on 06 February 1996.
The current directors of Giocon Pharma Limited are
The primary industry of Giocon Pharma Limited is Manufacturing.
Giocon Pharma Limited is unlisted.
The authorized capital of Giocon Pharma Limited is ₹1.50 Cr, and the paid-up capital is ₹1.32 Cr.
The compliance status of Giocon Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX